The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
- PMID: 33996551
- PMCID: PMC8117234
- DOI: 10.3389/fonc.2021.638048
The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
Abstract
Objective: MET positivity is independently associated with survival in oral squamous cell carcinoma (OSCC). Since MET is a known orchestrator of invasive tumor growth, we investigated its association with LNM in early oral tongue squamous cell carcinoma (OTSCC). As it is recommended by the NCCN to use tumor depth of invasion (DOI) in making decisions on elective neck dissection (END), the results obtained for MET positivity were aligned with those for DOI > 4 mm. The cutoff value used in our institution.
Methods: Tumor samples from patients who underwent primary tumor resection and neck dissection between 1995 and 2013, were collected from the archives of the Leiden and Erasmus University Medical Center. Immunohistochemistry with D1C2 was performed to identify MET negative (< 10% uniform positivity) and MET positive (≥ 10% uniform positivity) cancers. ROC curve analysis and the Chi-squared test were used to investigate the association of MET positivity with LNM (pN+ and occult). Binary logistic regression was used to investigate the association of MET positivity with LNM.
Results: Forty-five (44.1%) of the 102 cancers were MET positive. Ninety were cN0 of which 20 were pN+ (occult metastasis). The remaining 12 cancers were cN+, of which 10 were proven pN+ and 2 were pN0. MET positivity was associated with LNM with a positive predictive value (PPV) of 44.4% and a negative predictive value (NPV) of 82.5% for pN+. For the occult group, the PPV was 36.8% and the NPV was 88.5%. Regression analysis showed that MET positivity is associated with pN+ and occult LNM (p-value < 0.05).
Conclusion: MET positivity is significantly associated with LNM in early OTSCC, outperforming DOI. The added value of MET positivity could be in the preoperative setting when END is being considered during the initial surgery. For cases with DOI ≤ 4 mm, MET positivity could aid in the clinical decision whether regular follow-up, watchful waiting, or END is more appropriate. Realizing that these preliminary results need to be independently validated in a larger patient cohort, we believe that MET positivity could be of added value in the decision making on END in early OTSCC.
Keywords: MET; depth of invasion; elective neck dissection; occult lymph node metastasis; oral tongue squamous cell carcinoma.
Copyright © 2021 De Herdt, van der Steen, van der Toom, Aaboubout, Willems, Wieringa, Baatenburg de Jong, Looijenga, Koljenović and Hardillo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection.Oral Oncol. 2020 Dec;111:104940. doi: 10.1016/j.oraloncology.2020.104940. Epub 2020 Aug 5. Oral Oncol. 2020. PMID: 32769035
-
Is the Depth of Invasion a Marker for Elective Neck Dissection in Early Oral Squamous Cell Carcinoma?Front Oncol. 2021 Mar 12;11:628320. doi: 10.3389/fonc.2021.628320. eCollection 2021. Front Oncol. 2021. PMID: 33777774 Free PMC article.
-
Re-examining predictors of pathologic lymph node positivity in clinically node negative oral cavity cancer.Oral Oncol. 2023 Sep;144:106490. doi: 10.1016/j.oraloncology.2023.106490. Epub 2023 Jul 4. Oral Oncol. 2023. PMID: 37413770
-
The prognostic role of the pre-treatment neutrophil to lymphocyte ratio (NLR) and tumor depth of invasion (DOI) in early-stage squamous cell carcinomas of the oral tongue.Oral Maxillofac Surg. 2022 Mar;26(1):21-32. doi: 10.1007/s10006-021-00969-5. Epub 2021 Jun 9. Oral Maxillofac Surg. 2022. PMID: 34106358 Review.
-
Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis.Eur Arch Otorhinolaryngol. 2020 Jun;277(6):1741-1752. doi: 10.1007/s00405-020-05866-3. Epub 2020 Feb 25. Eur Arch Otorhinolaryngol. 2020. PMID: 32100133
Cited by
-
The role of unconventional lymph node metastasis in neck recurrence among patients with tongue cancer.Clin Oral Investig. 2023 Dec 22;28(1):13. doi: 10.1007/s00784-023-05421-4. Clin Oral Investig. 2023. PMID: 38129547
-
Identification of programmed cell death-related genes and construction of a prognostic model in oral squamous cell carcinoma using single-cell and transcriptome analysis.Discov Oncol. 2025 May 9;16(1):713. doi: 10.1007/s12672-025-02520-4. Discov Oncol. 2025. PMID: 40346375 Free PMC article.
-
Unveiling the best predictive models for early‑onset metastatic cancer: Insights and innovations (Review).Oncol Rep. 2024 Apr;51(4):60. doi: 10.3892/or.2024.8719. Epub 2024 Mar 8. Oncol Rep. 2024. PMID: 38456540 Free PMC article. Review.
-
Hsa_circ_0081069 facilitates tongue squamous cell carcinoma progression by modulating MAP2K4 expression via miR-634.Odontology. 2023 Apr;111(2):474-486. doi: 10.1007/s10266-022-00746-0. Epub 2022 Oct 1. Odontology. 2023. PMID: 36181561
-
The effect of postoperative adjuvant chemotherapy on survival outcomes in patients with early stage oral squamous cell carcinoma.Sci Rep. 2025 Jul 25;15(1):27157. doi: 10.1038/s41598-025-11565-y. Sci Rep. 2025. PMID: 40715317 Free PMC article.
References
-
- National Comprehensive Cancer Network . Nccn Clinical Practice Guidelines in Oncology (Nccn Guidelines) Head and Neck Cancers Version 2.2020 (2020). Available at: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.o....
-
- American Joint Commity on Cancer . Ajcc Cancer Staging Manual. 8th ed. New York: Springer; (2017).
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous